Comment on “Hall et al., Topical cannabidiol is well tolerated in individuals with a history of elite physical performance and chronic lower extremity pain”
March 18, 2024
J Cannabis Res. 2024 Mar 18;6(1):13. doi: 10.1186/s42238-023-00206-8.
NO ABSTRACT
PMID:38494522 | DOI:10.1186/s42238-023-00206-8